North Chicago Newswire

North Chicago Newswire

Comprehensive Real-Time News Feed for North Chicago, IL.

Results 1 - 5 of 5 for "u:biospace.com" in North Chicago, IL

  1. Biogen And AbbVie Receive Positive Opinion From The CHMP On ZINBRYTA...Read the original story

    Thursday Apr 28 | BioSpace

    CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.-- --The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the granting of a marketing authorization for ZINBRYTAa intended for the treatment of relapsing forms of multiple sclerosis , Biogen and AbbVie announced today.

    Comment?

  2. AbbVie Release: Data Presented At Highlight Impact Of ZINBRYTA...Read the original story

    Apr 19, 2016 | BioSpace

    AbbVie Release: Data Presented At AAN Highlight Impact Of ZINBRYTA On Cognitive Outcomes And The Reversibility Of Its Targeted Mechanism Of Action CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.-- --New data presented today show that investigational therapy ZINBRYTATM provided improvements on cognitive outcome measures in people living with relapsing forms of multiple sclerosis .

    Comment?

  3. AbbVie Coughs Up $595 Million+ for Boehringer Ingelheim's Psoriasis and Crohn??'s DrugsRead the original story

    Mar 7, 2016 | BioSpace

    March 7, 2016 By Mark Terry , BioSpace.com Breaking News Staff North Chicago, Ill.-based AbbVie and Germany-based Boehringer Ingelheim today that they have inked a global collaboration deal to develop and market BI 655066 for psoriasis . AbbVie is paying Boehringer Ingelheim $595 million upfront with additional development and regulatory milestones and royalties if the product makes it to market.

    Comment?

  4. AbbVie Coughs Up $595 Million+ for Boehringer Ingelheim's Psoriasis and Crohn??'s DrugsRead the original story

    Mar 6, 2016 | BioSpace

    March 7, 2016 By Mark Terry , BioSpace.com Breaking News Staff North Chicago, Ill.-based AbbVie and Germany-based Boehringer Ingelheim today that they have inked a global collaboration deal to develop and market BI 655066 for psoriasis . AbbVie is paying Boehringer Ingelheim $595 million upfront with additional development and regulatory milestones and royalties if the product makes it to market.

    Comment?

  5. AbbVie, Boehringer Ingelheim Rumored to Be in Cancer-Partnership TalksRead the original story

    Feb 27, 2016 | BioSpace

    February 29, 2016 By Mark Terry , BioSpace.com Breaking News Staff Unidentified inside sources are saying that Ingelheim , Germany-based Boehringer Ingelheim GmbH and North Chicago, Ill.-based AbbVie are considering a significant partnership in oncology. AbbVie spent much of last year in what appears to be a losing battle with Gilead, Inc. over the two companies' hepatitis C drugs.

    Comment?

North Chicago Job Listings
View or post North Chicago job listings on Topix.
North Chicago Real Estate
News, listings, and foreclosures in North Chicago from Topix.
North Chicago Mortgages
Find mortgage rates in North Chicago on Topix.